Spanish Red Biotech Pipeline

MSD

Lenvatinib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Children, Adolescents, and Young Adults with Relapsed or Refractory Solid Malignancies
Phase: 2Phase II in Spain, 1Phase I